Literature DB >> 16180120

Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells.

Takashi Nozawa1, Masato Suzuki, Hikaru Yabuuchi, Masanori Irokawa, Akira Tsuji, Ikumi Tamai.   

Abstract

PURPOSE: The aim of the study is to suppress the progress of estrogen-dependent breast cancer by inhibiting the membrane transporter, which mediates the internalization of estrone-3-sulfate as estrogen precursor in the cancer cells.
METHODS: The uptake of estrone-3-sulfate by estrogen-dependent breast cancer MCF-7 cells was measured, and inhibitory study using various organic anions on estrone-3-sulfate uptake by MCF-7 cells was conducted. The effects of the inhibitor on the transcription of reporter gene and cell proliferation induced by estrone-3-sulfate were examined.
RESULTS: The uptake of estrone-3-sulfate by MCF-7 cells was saturable with Km value of 2.32 microM. The uptake was Na+-independent and was inhibited by several anionic compounds such as bromosulfophthalein. Bromosulfophthalein also significantly inhibited the transcription of reporter gene via estrogen response element and cell proliferation induced by estrone-3-sulfate. However, the transcriptional activation or cell proliferation induced by estrone was not inhibited by bromosulfophthalein. Reverse transcription-polymerase chain reaction analysis revealed the expression of mRNA of organic anion transporting polypeptide (OATP)-D and OATP-E as possible candidates to transport estrone-3-sulfate.
CONCLUSIONS: The uptake of estrone-3-sulfate is mediated by Na+-independent transporter(s). Inhibitor of estrone-3-sulfate transporter suppressed the transcription and cell proliferation induced by estrone-3-sulfate in MCF-7 cells. The results provide the basis of a novel strategy for breast cancer treatment by focusing on the transporter responsible for the uptake of estrone-3-sulfate.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16180120     DOI: 10.1007/s11095-005-7096-0

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  The characterization of estrone sulfate from human plasma.

Authors:  R H PURDY; L L ENGEL; J L ONCLEY
Journal:  J Biol Chem       Date:  1961-04       Impact factor: 5.157

2.  Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells.

Authors:  Takashi Nozawa; Masato Suzuki; Koichi Takahashi; Hikaru Yabuuchi; Tomoji Maeda; Akira Tsuji; Ikumi Tamai
Journal:  J Pharmacol Exp Ther       Date:  2004-08-24       Impact factor: 4.030

3.  Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080.

Authors:  T Nakanishi; I Tamai; Y Sai; T Sasaki; A Tsuji
Journal:  Cancer Res       Date:  1997-09-15       Impact factor: 12.701

4.  Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family.

Authors:  I Tamai; J Nezu; H Uchino; Y Sai; A Oku; M Shimane; A Tsuji
Journal:  Biochem Biophys Res Commun       Date:  2000-06-24       Impact factor: 3.575

5.  Functional characterization of human organic anion transporting polypeptide B (OATP-B) in comparison with liver-specific OATP-C.

Authors:  I Tamai; T Nozawa; M Koshida; J Nezu; Y Sai; A Tsuji
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

Review 6.  Trastuzumab, a recombinant DNA-derived humanized monoclonal antibody, a novel agent for the treatment of metastatic breast cancer.

Authors:  M M Goldenberg
Journal:  Clin Ther       Date:  1999-02       Impact factor: 3.393

7.  LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers.

Authors:  T Abe; M Unno; T Onogawa; T Tokui; T N Kondo; R Nakagomi; H Adachi; K Fujiwara; M Okabe; T Suzuki; K Nunoki; E Sato; M Kakyo; T Nishio; J Sugita; N Asano; M Tanemoto; M Seki; F Date; K Ono; Y Kondo; K Shiiba; M Suzuki; H Ohtani; T Shimosegawa; K Iinuma; H Nagura; S Ito; S Matsuno
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

8.  Elevated steroid sulfatase expression in breast cancers.

Authors:  T Utsumi; N Yoshimura; S Takeuchi; M Maruta; K Maeda; N Harada
Journal:  J Steroid Biochem Mol Biol       Date:  2000-06       Impact factor: 4.292

9.  Characterization of structural and functional properties of human 17 beta-hydroxysteroid dehydrogenase type 1 using recombinant enzymes and site-directed mutagenesis.

Authors:  T Puranen; M Poutanen; D Ghosh; P Vihko; R Vihko
Journal:  Mol Endocrinol       Date:  1997-01

Review 10.  The selective estrogen enzyme modulators in breast cancer: a review.

Authors:  Jorge R Pasqualini
Journal:  Biochim Biophys Acta       Date:  2004-06-07
View more
  21 in total

1.  Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

Authors:  Juma Hoshino; Eun-Jung Park; Tamara P Kondratyuk; Laura Marler; John M Pezzuto; Richard B van Breemen; Shunyan Mo; Yongchao Li; Mark Cushman
Journal:  J Med Chem       Date:  2010-07-08       Impact factor: 7.446

Review 2.  Minireview: SLCO and ABC transporters: a role for steroid transport in prostate cancer progression.

Authors:  Eunpi Cho; R Bruce Montgomery; Elahe A Mostaghel
Journal:  Endocrinology       Date:  2014-08-22       Impact factor: 4.736

3.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.

Authors:  Jonathan L Wright; Erika M Kwon; Elaine A Ostrander; R Bruce Montgomery; Daniel W Lin; Robert Vessella; Janet L Stanford; Elahe A Mostaghel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-25       Impact factor: 4.254

4.  Contribution of Organic Anion-Transporting Polypeptides 1A/1B to Doxorubicin Uptake and Clearance.

Authors:  Hannah H Lee; Brenda F Leake; Richard B Kim; Richard H Ho
Journal:  Mol Pharmacol       Date:  2016-10-24       Impact factor: 4.436

Review 5.  The expression and function of organic anion transporting polypeptides in normal tissues and in cancer.

Authors:  Amanda Obaidat; Megan Roth; Bruno Hagenbuch
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-15       Impact factor: 13.820

Review 6.  Organic Anion Transporting Polypeptides: Emerging Roles in Cancer Pharmacology.

Authors:  Rachael R Schulte; Richard H Ho
Journal:  Mol Pharmacol       Date:  2019-02-19       Impact factor: 4.436

7.  (125)I-Labelled 2-Iodoestrone-3-sulfate: synthesis, characterization and OATP mediated transport studies in hormone dependent and independent breast cancer cells.

Authors:  Nilasha Banerjee; T Robert Wu; Jason Chio; Ryan Kelly; Karin A Stephenson; John Forbes; Christine Allen; John F Valliant; Reina Bendayan
Journal:  Nucl Med Biol       Date:  2014-11-08       Impact factor: 2.408

8.  Overexpression of OATP1B3 confers apoptotic resistance in colon cancer.

Authors:  Wooin Lee; Abbes Belkhiri; A Craig Lockhart; Nipun Merchant; Hartmut Glaeser; Elizabeth I Harris; M Kay Washington; Elizabeth M Brunt; Alex Zaika; Richard B Kim; Wael El-Rifai
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

9.  Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives.

Authors:  Yuchen Zhang; Amanda Hays; Alexander Noblett; Mahendra Thapa; Duy H Hua; Bruno Hagenbuch
Journal:  J Nat Prod       Date:  2013-01-17       Impact factor: 4.050

10.  Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer.

Authors:  Henriette E Meyer zu Schwabedissen; Rommel G Tirona; Cindy S Yip; Richard H Ho; Richard B Kim
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.